Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Technologies - Radioactive and Nonradioactive Probes: Radiopharmacy

An attractive approach for HPLC detection of both β+/β- emitters

Noeen Malik, Felix Arndt, Thomas Kull, Boris Zlatopolskiy, Christoph Solbach, Sven Reske and Hans-Jürgen Machulla
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1640;
Noeen Malik
1Clinic for Nuclear Medicine, Ulm University, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felix Arndt
1Clinic for Nuclear Medicine, Ulm University, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Kull
1Clinic for Nuclear Medicine, Ulm University, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Boris Zlatopolskiy
1Clinic for Nuclear Medicine, Ulm University, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Solbach
1Clinic for Nuclear Medicine, Ulm University, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sven Reske
1Clinic for Nuclear Medicine, Ulm University, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Jürgen Machulla
1Clinic for Nuclear Medicine, Ulm University, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1640

Objectives For metabolic studies of tracers labeled with PET radionuclides and “classic” radionuclides such as C-14 and tritium, on-line detection of β+/β- particles in radio-HPLC is essential.Since special Li-glasses (GS1) are available as internal solid scintillators, we evaluated the applicability of such a detector for metabolites labeled with N-13, C-14 and tritium, F-18, C-11 as well as in dual isotope studies.

Methods HPLC system was used with a Ramona as β-detector (raytest, Germany) in line. For calibration, 13NH3, [18F]FDG (140MBq/0.1mL), [11C]choline (108MBq/0.1mL), [3H]acetic acid (185MBq/mL), and [14C]aspartic acid (3.7MBq/mL),were used. Dilutions by a factor up to 10-100,000 were made. For analysis of 14C-labeled and 3H-labeled amino acids, SCX Partisil column was used. The system was also utilized for assessing the purity of commercially available [14C]proline, [14C]glutamic acid, [14C]aspartic acid, [14C]glutamine, [14C]alanine, [14C]urea (37MBq/mL), [3H]glutamic acid, and [3H]alanine. For dual isotope studies, a mixture of 13N- and 14C-amino acids was analysed by same HPLC conditions. Similar system was used for analysis of 13N-labeled amino acids in animal experiments.

Results Though certified with a purity of 99%, [14C]glutamic acid, [14C]aspartic acid and [14C]proline showed impurities of 20%, 10% and 72%, respectively. Calibration was carried out for 13N with 13NH3 (linear response interval:0.7-10kBq). A good recognition of an activity peak was possible at 40Bq for both 13N and 14C, 5kBq for 3H, 20Bq for both 11C and 18F. In dual isotope studies with 13N and 14C amino acids, the mixture of β+ and β- emitters was registered and after decay of 13N, analysis was repeated for measurement of 14C. That type of radiochemical standard approach allowed to detect even low activities (40Bq) of 14C.

Conclusions Detection of β+/β- by Ramona was performed with a high sensitivity substituting the need of final liquid scintillator. For biological applications, the data illustrated the need to critically check the purity of commercially obtained radio-labeled tracers

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
An attractive approach for HPLC detection of both β+/β- emitters
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
An attractive approach for HPLC detection of both β+/β- emitters
Noeen Malik, Felix Arndt, Thomas Kull, Boris Zlatopolskiy, Christoph Solbach, Sven Reske, Hans-Jürgen Machulla
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1640;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
An attractive approach for HPLC detection of both β+/β- emitters
Noeen Malik, Felix Arndt, Thomas Kull, Boris Zlatopolskiy, Christoph Solbach, Sven Reske, Hans-Jürgen Machulla
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1640;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Technologies - Radioactive and Nonradioactive Probes: Radiopharmacy

  • Simple automated radiosynthesis of 10-[11C]methoxy-20(S)-camptothecin and biodistribution in normal mice
  • Potential evaluation of 111In-Hexa lactoside as a novel functional liver imaging agent
  • Modified technique for manual synthesis of 68Ga-Citrate with high radiochemical purity
Show more Molecular Targeting Technologies - Radioactive and Nonradioactive Probes: Radiopharmacy

Radiopharmacy Posters

  • Resazurin as System Suitability Indicator for Radio-TLC Analysis of [18F] Fludeoxyglucose
  • The Shortage of Approved 68Ge/68Ga Generators - Incoming Material Inspection and GMP Compliant Use of Non-Approved Generators
  • [18F]FBQ-C2 as a metabolically stable glutamine derivative for cancer imaging
Show more Radiopharmacy Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire